))
In our series of podcasts, FIECON team members engage with patient advocates and thought leaders to explore the burden, unmet needs, patient journey, and potential future treatments for specific diseases, with the aim of gaining a deeper understanding of the patient's perspective, particularly for rare diseases. At FIECON, we are dedicated to ensuring that life-changing treatments reach the patients who truly need them, while also increasing awareness and amplifying the patient voice to make ...
…
continue reading
1
The patient journey | Citrullinaemia Type 1
26:02
26:02
Na później
Na później
Listy
Polub
Polubione
26:02
In this episode of, Daniel Evans , HEOR Associate at FIECON, speaks with Charlotte Keys, a patient advocate, whose son Lucas was diagnosed with Citrullinaemia Type 1, and Jonathan Alexander Gibson, Campaigns Lead at Metabolic Support UK .
…
continue reading
1
The patient journey | Sickle cell disease
31:56
31:56
Na później
Na później
Listy
Polub
Polubione
31:56
In this episode, Tyler Piazza, BD Director at FIECON, hosts an insightful interview with Kevin Wake, CMR, CHW, M.S., a sickle cell disease patient advocacy leader and a health outcomes industry expert. Kevin, who was diagnosed with sickle cell disease at nine months old, is now the president of URIEL E OWENS SICKLE CELL DISEASE ASSOCIATION OF THE M…
…
continue reading
1
The patient journey | Metastatic breast cancer
41:38
41:38
Na później
Na później
Listy
Polub
Polubione
41:38
In this episode Karl Freemyer, BD director at FIECON, is speaking with Emma Chaffin about her experience living with the metastatic breast cancer as a biopharmaceutical executive. Emma is a resilient breast cancer survivor who was diagnosed with stage 4 breast cancer five years ago at the age of 41. Facing a daunting prognosis and a treatment plan …
…
continue reading
1
The patient journey | Von Hippel-Lindau syndrome (VHL)
17:03
17:03
Na później
Na później
Listy
Polub
Polubione
17:03
Von Hippel-Lindau syndrome (VHL), is an inherited condition that brings about tumors in various organs, particularly hemangioblastomas, which are blood vessel tumors found in the brain, spinal cord, and retina. Listen to FIECON's latest 'Patient Perspectives' podcast with Lauren Weinberg, Senior Associate at FIECON, talking to Frankie Bryant about …
…
continue reading
1
The patient journey | Leber hereditary optic neuropathy (LHON)
17:35
17:35
Na później
Na później
Listy
Polub
Polubione
17:35
In this podcast, Lily Mumford talks to Lauren Weinberg, Senior Associate at FIECON, about her patient journey, experience living with LHON, and how losing her vision has impacted her life. Leber hereditary optic neuropathy (LHON) is a rare condition that primarily affects young adults. It causes painless vision loss, typically starting in one eye a…
…
continue reading
1
The patient journey | FOP (Fibrodysplasia Ossificans Progressiva ), Lexi's story
29:55
29:55
Na później
Na później
Listy
Polub
Polubione
29:55
In this podcast, David Robins talks to Lauren Weinberg, Senior Associate at FIECON, about the patient journey, his experience as the father of Lexi who lives with Fibrodysplasia Ossificans Progressiva (FOP), and as a family after the FOP diagnosis. FOP is an ultra-rare genetic condition and is one of the most debilitating conditions known to medici…
…
continue reading
1
The patient journey | SATB2-associated syndrome (SAS)
21:55
21:55
Na później
Na później
Listy
Polub
Polubione
21:55
Erika Stariha is the mother of the first child in Slovenia diagnosed with SATB2-associated syndrome (SAS), as well as the founder and president of SATB2-Europe. SATB2 Europe's aim is: “To improve quality of life for individuals with SATB2 syndrome through discovery and development of targeted treatments and enhanced availability of appropriate care…
…
continue reading
1
The patient journey | Acanthamoeba keratitis
34:57
34:57
Na później
Na później
Listy
Polub
Polubione
34:57
Juliette Vila Sinclair-Spence is a passionate Acanthamoeba keratitis (AK) Warrior and Rare Disease Patient Advocate as well as the Founder and Chairwoman of Acanthamoeba keratitis (AK) Eye Foundation. With her patient voice, she brings personal and first-hand experience of what it means to be affected by Acanthamoeba keratitis as well as its afterm…
…
continue reading
1
The patient journey | Dravet syndrome
24:03
24:03
Na później
Na później
Listy
Polub
Polubione
24:03
José Ángel Aibar became involved in the activities of the Dravet Syndrome Foundation, shortly after one of his sons was diagnosed with Dravet syndrome. He has served as President and CEO since June 2018. José is also a member of several rare disease and epilepsy working groups, such as Epag EpiCARE and the Eurordis Digital and Data Advisory Group, …
…
continue reading
1
Access for rare diseases - how to navigate conflict, compromise and collaboration
35:09
35:09
Na później
Na później
Listy
Polub
Polubione
35:09
World Orphan Drug Congress panel discussion November 2021 "Access for rare diseases - how to navigate conflict, compromise and collaboration" with panellists - Karl Freemyer, Head of Business Development - FIECON (host) Martin Schuchardt, Director of Pricing and Market Access - FIECON Simon Eade, Vice president of Worldwide global strategy - Jansse…
…
continue reading
Pompe disease is a rare (estimated at 1 in every 40,000 births), inherited and often fatal disorder that disables the heart and skeletal muscles. It is caused by mutations in a gene that makes an enzyme called acid alpha-glucosidase (GAA). Normally, the body uses GAA to break down glycogen, a stored form of sugar used for energy. Infantile Pompe di…
…
continue reading
1
The patient journey | Fibrodysplasia Ossificans Progressiva (FOP)
26:39
26:39
Na później
Na później
Listy
Polub
Polubione
26:39
Chris and Helen Bedford - Gay are the founders and patient advocacy leaders at FOP Friends charity. In 2009 their first child, Oliver, was diagnosed with FOP, aged just one. FOP Friends’ aim is to further research into Fibrodysplasia Ossificans Progressiva (FOP) and related conditions by supporting current and future research projects. In this podc…
…
continue reading
In this podcast, Patient X talks to us about her patient journey and her experiences, as both a patient and patient advocacy leader. Five years ago, a high impact event led to Patient X being diagnosed with chronic migraines. Patient X is a volunteer with several migraine and headache non-profit organisations, she has a Master of Public Health and …
…
continue reading
1
The patient journey | ATTR (transthyretin) amyloidosis and wild type amyloidosis disease
33:55
33:55
Na później
Na później
Listy
Polub
Polubione
33:55
Vince Nicholas and Paul Pozzo are patient advocacy leaders at the UK ATTR amyloidosis Patient Association. Each live with a variant of the rare disease amyloidosis; ATTR (transthyretin) amyloidosis and wild-type amyloidosis, respectively. In this podcast they talk to us about their patient journey and their experiences as both patients and patient …
…
continue reading
